A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
复制标题
DOI:
10.1136/annrheumdis-2016-209519
复制
发表时间:
2017-03-01
影响因子:
27.4
通讯作者:
Ward, Michael
中科院分区:
文献类型:
--
作者:
van Vollenhoven, Ronald;Voskuyl, Alexandre;Ward, Michael
Objectives Treat-to-target recommendations have identified `remission' as a target in systemic lupus erythematosus (SLE), but recognise that there is no universally accepted definition for this. Therefore, we initiated a process to achieve consensus on potential definitions for remission in SLE.Methods An international task force of 60 specialists and patient representatives participated in preparatory exercises, a face-to-face meeting and follow-up electronic voting. The level for agreement was set at 90%.Results The task force agreed on eight key statements regarding remission in SLE and three principles to guide the further development of remission definitions:1. Definitions of remission will be worded as follows: remission in SLE is a durable state characterised by ... (reference to symptoms, signs, routine labs).2. For defining remission, a validated index must be used, for example, clinical systemic lupus erythematosus disease activity index (SLEDAI)=0, British Isles lupus assessment group (BILAG) 2004 D/E only, clinical European consensus lupus outcome measure (ECLAM)=0; with routine laboratory assessments included, and supplemented with physician's global assessment.3. Distinction is made between remission off and on therapy: remission off therapy requires the patient to be on no other treatment for SLE than maintenance antimalarials; and remission on therapy allows patients to be on stable maintenance antimalarials, low-dose corticosteroids (prednisone